我国基本药物招标采购现状分析与建议  

Analysis and Suggestion on the Current Situation of the Essential Medicine Bidding and Procurement in China

作　　者：金春林 王丽洁[2] 段光锋[2] 田文华[2] 李芬 

机构地区：[1]上海市卫生发展研究中心,上海200040 [2]第二军医大学卫生事业管理学教研室,上海200433

出　　处：《中国卫生经济》2013年第9期80-81,共2页Chinese Health Economics

基　　金：卫生部药政司2012年招标项目;2012年上海市卫生局青年科研项目

摘　　要：目的:对国家基本药物采购指导意见颁布以来,各地实践中发现的主要问题进行梳理和分析,并提出改革建议。方法:文献系统综述与理论分析。结果:当前基本药物招标采购主要问题包括经济技术标难以有效评价药品质量、招采主体分离导致量价难挂钩、中标价格虚低影响药品可及性,以及质量分层招标拉大药品价格差距等。药品同质性是"双信封"模式的基础,供方用药行为则是影响药品实际采购量的关键。结论:在竞争性招标采购策略的实施条件尚不具备的情况下,将难以获得合理的采购价格。因此,需要完善基本药物质量评价体系,整合招标与采购主体提高采购效率,并通过干预供方行为促进合理用药结果。Objective： According to the national essential guidance on the medicine bidding and procurement, to analyze main problems from the practices and propose suggestion to reform. Methods： The overview of documentation system and theoretical analysis. Results： The main problems include difficulties to qualify products by economic technical standard; the separation of tender and bidder results in the irrelativeness between qualities and prices;the inappropriate low prices of the wined products affect the popularizing rate of the medicine; and the layered bidding broadens the medical price gap. Conclusion： Since the required implement of the competitive bidding and procurement policy has not been completed, it is difficult to receive reasonable purchasing prices. Therefore, it requires completing the evaluating system of essential medicine quality, combining the tender and the bidder to improve the purchasing efficiency, and boosting the rationalization of medical usage through intervene the behavior of the provider.Abstract Objective： According to the national essential guidance on the medicine bidding and procurement, to analyze main problems from the practices and propose suggestion to reform. Methods： The overview of documentation system and theoretical analysis. Results： The main problems include difficulties to qualify products by economic technical standard; the separation of tender and bidder results in the irrelativeness between qualities and prices;the inappropriate low prices of the wined products affect the popularizing rate of the medicine; and the layered bidding broadens the medical price gap. Conclusion： Since the required implement of the competitive bidding and procurement policy has not been completed, it is difficult to receive reasonable purchasing prices. Therefore, it requires completing the evaluating system of essential medicine quality, combining the tender and the bidder to improve the purchasing efficiency, and boosting the rationalization of medical usage through intervene th

关 键 词：基本药物 招标采购 基本药物质量评价体系 采购效率 

分 类 号：R95[医药卫生—药学]